Načítá se...
Exploitation of Precision Medicine Trials Data: Examples of Long Responders From the SHIVA01 Trial
PURPOSE: Precision medicine trials constitute a precious source of molecular data with prospective clinical annotations allowing the exploration of patients’ subpopulations according to specific clinical or biological questions. Using the SHIVA01—the first randomized trial comparing molecularly targ...
Uloženo v:
| Vydáno v: | JCO Precis Oncol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society of Clinical Oncology
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7450915/ https://ncbi.nlm.nih.gov/pubmed/32914004 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.18.00048 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|